KARYN PAUZE: Open Payments
NPI 1265610893 · ALTAMONT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 58 payments from 18 companies in 2025. Trend: 2023 $1,135 · 2024 $2,039 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $290 |
| GENZYME CORPORATION | 4 | $111 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $92 |
| Lilly USA, LLC | 4 | $86 |
| LEO Pharma Inc. | 4 | $82 |
| Galderma Laboratories, L.P. | 4 | $70 |
| UCB, Inc. | 2 | $63 |
| Incyte Corporation | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Organon LLC | 2 | $44 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, TALTZ, ILUMYA, Bimzelx, ADBRY, OPZELURA.
Industry payments across NY — which companies pay providers there.
